Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Dermatology (Basel, Switzerland)|June 21, 2016
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisAntonios G A Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 24, 2022
Association between allergic sensitization and intestinal parasite infection in schoolchildren in Gqeberha, South AfricaOliver Brandt, Benjamin Wegenstein, Ivan Müller, et al.
Acta Dermato-Venereologica|May 18, 2019
Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional StudyFlorian Anzengruber, Matthias Augustin, Marc A Radtke, et al.
Dermatology (Basel, Switzerland)|November 14, 2017
Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum PatientsAntonios G A Kolios, Alissa Gübeli, Barbara Meier, et al.
The British Journal of Dermatology|April 10, 2021
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry studyJ-T Maul, M Augustin, C Sorbe, et al.
Dermatology (Basel, Switzerland)|September 11, 2025
Dimethyl Fumarate Treatment for Psoriasis in Real-World Clinical Practice: An Analysis from the Swiss RegistryLara Valeska Maul, Melike Ak, Sara E Cerminara, et al.
The Journal of Clinical Investigation|September 7, 2006
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signalingKarl S Lang, Panco Georgiev, Mike Recher, et al.
Frontiers in Medicine|April 1, 2026
Acyl-CoA synthetase long-chain family member 4-A novel prognostic marker in cutaneous melanomaSoumya Paria, Rebecca Lapides, Babak Saravi, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
BMJ Open|March 31, 2021
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flareSiew Eng Choon, Mark G Lebwohl, Slaheddine Marrakchi, et al.
Pageof 20